Proscia Secures $50M Investment to Accelerate AI Pathology

Proscia, a software company innovating in the field of pathology, has raised $50 million in funding, bringing its total raised to $130 million. The fundraiser was led by Insight Partners with participation from several other notable investors including AI Capital Partners, Triangle Peak Partners, and Razor's Edge Ventures LLC. Proscia's platform, Concentriq, is at the forefront of digitizing and integrating AI into pathology to improve diagnostics, accelerate the development of new therapies, and enhance precision medicine. The company aims to address current challenges in pathology such as workforce shortages and increasing case volumes by transitioning from traditional microscopy to AI-driven, data-rich imaging methodologies. With this recent funding, Proscia plans to scale its operations, expand the functionalities of Concentriq, and further integrate AI at its core, thus solidifying its leadership in digital pathology.